MCID: OVR018
MIFTS: 11

Ovarian Clear Cell Malignant Adenofibroma

Categories: Endocrine diseases, Reproductive diseases, Cancer diseases

Aliases & Classifications for Ovarian Clear Cell Malignant Adenofibroma

MalaCards integrated aliases for Ovarian Clear Cell Malignant Adenofibroma:

Name: Ovarian Clear Cell Malignant Adenofibroma 12
Ovarian Clear Cell Adenocarcinofibroma 12 73

Classifications:



External Ids:

Disease Ontology 12 DOID:6554
NCIt 50 C40079
UMLS 73 C2075522

Summaries for Ovarian Clear Cell Malignant Adenofibroma

MalaCards based summary : Ovarian Clear Cell Malignant Adenofibroma, is also known as ovarian clear cell adenocarcinofibroma. The drugs Gemcitabine and Carboplatin have been mentioned in the context of this disorder. Affiliated tissues include endothelial.

Related Diseases for Ovarian Clear Cell Malignant Adenofibroma

Diseases in the Ovarian Clear Cell Adenofibroma family:

Ovarian Clear Cell Malignant Adenofibroma

Symptoms & Phenotypes for Ovarian Clear Cell Malignant Adenofibroma

Drugs & Therapeutics for Ovarian Clear Cell Malignant Adenofibroma

Drugs for Ovarian Clear Cell Malignant Adenofibroma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 21)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Gemcitabine Approved Phase 3 95058-81-4 60750
2
Carboplatin Approved Phase 3 41575-94-4 10339178 498142 38904
3
Paclitaxel Approved, Vet_approved Phase 3 33069-62-4 36314
4
Docetaxel Approved, Investigational Phase 3 114977-28-5 148124
5
Bevacizumab Approved, Investigational Phase 3 216974-75-3
6 Mitogens Phase 3
7 Albumin-Bound Paclitaxel Phase 3
8 Angiogenesis Inhibitors Phase 3
9 Angiogenesis Modulating Agents Phase 3
10 Endothelial Growth Factors Phase 3
11 Immunoglobulin G Phase 3
12 Antibodies Phase 3
13 Immunoglobulins Phase 3
14 Antibodies, Monoclonal Phase 3
15 Immunosuppressive Agents Phase 3
16 Anti-Infective Agents Phase 3
17 Antimetabolites Phase 3
18 Antiviral Agents Phase 3
19 Antimetabolites, Antineoplastic Phase 3
20 Antimitotic Agents Phase 3
21 Antineoplastic Agents, Phytogenic Phase 3

Interventional clinical trials:


# Name Status NCT ID Phase Drugs
1 Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer Active, not recruiting NCT01167712 Phase 3 Carboplatin;Paclitaxel
2 Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer Active, not recruiting NCT00565851 Phase 3 Carboplatin;Docetaxel;Gemcitabine Hydrochloride;Paclitaxel

Search NIH Clinical Center for Ovarian Clear Cell Malignant Adenofibroma

Genetic Tests for Ovarian Clear Cell Malignant Adenofibroma

Anatomical Context for Ovarian Clear Cell Malignant Adenofibroma

MalaCards organs/tissues related to Ovarian Clear Cell Malignant Adenofibroma:

41
Endothelial

Publications for Ovarian Clear Cell Malignant Adenofibroma

Variations for Ovarian Clear Cell Malignant Adenofibroma

Expression for Ovarian Clear Cell Malignant Adenofibroma

Search GEO for disease gene expression data for Ovarian Clear Cell Malignant Adenofibroma.

Pathways for Ovarian Clear Cell Malignant Adenofibroma

GO Terms for Ovarian Clear Cell Malignant Adenofibroma

Sources for Ovarian Clear Cell Malignant Adenofibroma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....